Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
GL

Genpharmasec Ltd

531592·Commercial Services & Supplies

Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity sharesBusiness Overview: GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to...

54Announcements
08-09-2026Last filed
12Last 90 days
genpharmasec.com

What Genpharmasec files

  • Board Meeting15
  • Important14
  • Others11
  • Updates7
  • Insider Trading3
  • Results2
Showing Important announcements (14)Clear filter
02-09-2026 · 03:52 pm

GENPHARMASEC's board has approved its 34th Annual General Meeting (AGM) for September 29, 2026, to be held virtually. Key dates for e-voting (September 26-28, 2026) and book closure (September 23-29, 2026) were also set. The board approved the Annual Report and Director's Report for the financial year 2025-26. Shareholders will...

Read the full announcement→
PDF
11-08-2026 · 04:21 pm

Genpharmasec Limited confirmed there is no deviation in how it has used the Rs. 48.45 crore raised from its Rights Issue. The funds are being utilized as per the original plan disclosed in the Letter of Offer. Key uses include acquiring shares in Derren Healthcare Private Limited, partially repaying borrowings,...

Read the full announcement→
PDF
07-07-2026 · 11:17 am

Genpharmasec Limited has received a confirmation from its Registrar and Share Transfer Agent (RTA) regarding share dematerialization. The RTA confirmed that no physical share certificates were submitted for dematerialization during the period. This update, part of standard market procedures, assures investors that the company's processes for handling share transfers are...

Read the full announcement→
PDF
23-05-2026 · 10:53 am

Genpharmasec has published its audited consolidated and standalone financial results for the quarter and year. For the full year, consolidated total income from operations was 143.09 Cr, achieving a net profit after tax of 0.56 Cr, with basic EPS at 0.01. For the final quarter alone, consolidated income reached 56.44...

Read the full announcement→
PDF
08-04-2026 · 10:54 am

Genpharmasec Limited has provided its quarterly compliance update regarding share transfer and dematerialization processes. For the period ending March 31, 2026, the company's Registrar and Share Transfer Agent confirmed that no physical share certificates were received for dematerialization. This means all shareholder requests for converting physical shares to electronic form...

Read the full announcement→
PDF